Clinical Endoscopy

The Korean Society of Gastrointestinal Endoscopy (대한소화기내시경학회)
권호 표지
DOI QR코드

DOI QR Code

Exploring quality indicators for the detection of Helicobacter pylori-naïve gastric cancer: a cross-sectional nationwide survey

  • Fumiaki Ishibashi (Department of Gastroenterology, International University of Health and Welfare Ichikawa Hospital) ;
  • Toshiaki Hirasawa (Department of Gastroenterology, Cancer Institute Hospital) ;
  • Hiroya Ueyama (Department of Gastroenterology, Juntendo University School of Medicine) ;
  • Yohei Minato (Department of Gastrointestinal Endoscopy, NTT Medical Center Tokyo) ;
  • Sho Suzuki (Department of Gastroenterology, International University of Health and Welfare Ichikawa Hospital)
  • Received : 2022.06.10
  • Accepted : 2022.07.11
  • Published : 2023.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background/Aims: Diagnosis of Helicobacter pylori-naive gastric cancer (HPNGC) is becoming increasingly important. This study aimed to explore the quality indicators for HPNGC detection. Methods: We conducted a cross-sectional, nationwide, web-based survey of gastrointestinal endoscopists in Japan. In addition to questions about the number of HPNGC cases detected in a year and basic information, the questionnaire also consisted of 28 questions: (1) 18 about HPNGC awareness, (2) six about diagnostic proactiveness, and (3) four about interest in HPNGC. Results: Valid responses were obtained from 712 endoscopists. The Japan Gastroenterological Endoscopy Society-certified endoscopists had a significantly higher HPNGC detection rate than the nonspecialists (0.42% vs. 0.32%, respectively; p=0.008). The results of the multiple regression analysis showed that Japan Gastroenterological Endoscopy Society certification and high awareness and interest scores were independent predictors of the HPNGC detection rate (p=0.012, p<0.001, p=0.024, respectively). Principal component analysis showed that the endoscopists who attended conferences for collecting information on HPNGC had a higher level of awareness. Conclusions: To improve the detection of HPNGC, it is necessary to increase the awareness of the disease. It is hoped that relevant societies will play an important role in endoscopists' education.

Keywords

References

  1. Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-1136. https://doi.org/10.1056/NEJM199110173251604
  2. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-353. https://doi.org/10.1136/gut.49.3.347
  3. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:392-397. https://doi.org/10.1016/S0140-6736(08)61159-9
  4. Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med 2018;378:1085-1095. https://doi.org/10.1056/NEJMoa1708423
  5. Inoue M. Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer 2017;20(Suppl 1):3-7. https://doi.org/10.1007/s10120-016-0658-5
  6. Wang C, Nishiyama T, Kikuchi S, et al. Changing trends in the prevalence of H. pylori infection in Japan (1908-2003): a systematic review and meta-regression analysis of 170,752 individuals. Sci Rep 2017;7:15491.
  7. Watanabe M, Ito H, Hosono S, et al. Declining trends in prevalence of Helicobacter pylori infection by birth-year in a Japanese population. Cancer Sci 2015;106:1738-1743. https://doi.org/10.1111/cas.12821
  8. Matsuo T, Ito M, Takata S, et al. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter 2011;16:415-419. https://doi.org/10.1111/j.1523-5378.2011.00889.x
  9. Kiso M, Yoshihara M, Ito M, et al. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study. Gastric Cancer 2017;20:764-771. https://doi.org/10.1007/s10120-016-0682-5
  10. Nikaido M, Kakiuchi N, Miyamoto S, et al. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations. Gastric Cancer 2021;24:1102-1114. https://doi.org/10.1007/s10120-021-01191-8
  11. Kiso M, Urabe Y, Ito M, et al. Clinical and genomic characteristics of mucosal signet-ring cell carcinoma in Helicobacter pylori-uninfected stomach. BMC Gastroenterol 2020;20:243.
  12. Ueyama H, Yao T, Nakashima Y, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol 2010;34:609-619. https://doi.org/10.1097/PAS.0b013e3181d94d53
  13. Ueyama H, Matsumoto K, Nagahara A, et al. Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy 2014;46:153-157.
  14. Ueyama H, Yao T, Akazawa Y, et al. Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type. J Gastroenterol 2021;56:814-828. https://doi.org/10.1007/s00535-021-01813-z
  15. Ishibashi F, Fukushima K, Ito T, et al. Influence of Helicobacter pylori infection on endoscopic findings of gastric adenocarcinoma of the fundic gland type. J Gastric Cancer 2019;19:225-233. https://doi.org/10.5230/jgc.2019.19.e21
  16. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011;14:113-123. https://doi.org/10.1007/s10120-011-0042-4
  17. Shibagaki K, Fukuyama C, Mikami H, et al. Gastric foveolar-type adenomas endoscopically showing a raspberry-like appearance in the Helicobacter pylori-uninfected stomach. Endosc Int Open 2019;7:E784-791. https://doi.org/10.1055/a-0854-3818
  18. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-9. https://doi.org/10.1111/apm.1965.64.1.31
  19. Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumors of the digestive system. 4th ed. Lyon: JARC; 2010.
  20. Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020;76:182-188. https://doi.org/10.1111/his.13975
  21. Sato C, Hirasawa K, Tateishi Y, et al. Clinicopathological features of early gastric cancers arising in Helicobacter pylori uninfected patients. World J Gastroenterol 2020;26:2618-2631. https://doi.org/10.3748/wjg.v26.i20.2618
  22. Ishibashi F, Kobayashi K, Fukushima K, et al. Quality indicators for the detection of Helicobacter pylori-negative early gastric cancer: a retrospective observational study. Clin Endosc 2020;53:698-604.
  23. Ishibashi F, Kobayashi K, Kawakami T, et al. Quality management system for screening esophagogastroduodenoscopy improves detection of Helicobacter pylori-negative interval gastric cancer. Endosc Int Open 2021;9:E1900-1908. https://doi.org/10.1055/a-1594-1833
  24. Lee SY, Yoshida N, Dohi O, et al. Differences in prevalence of lymphovascular invasion among early gastric cancers between Korea and Japan. Gut Liver 2017;11:383-391. https://doi.org/10.5009/gnl16281
  25. R Core Team. A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2022 [cited 2022 Mar 3]. Available from: https://www.R-project.org/.